Helicobacter Pylori infection is a significant risk for modified lipid profile in Japanese male subjects

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 10, 2010, Pages 1041-1048

  Satoh, Hiroki ^a   Saijo, Yasuaki ^b   Yoshioka, Eiji ^a   Tsutsui, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Helicobacter pylori; High density lipoprotein cholesterol; Japanese population; Low density lipoprotein cholesterol

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HELICOBACTER INFECTION; HUMAN; HYPERCHOLESTEROLEMIA; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 78249238492     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.5157     Document Type: Article

References (33)

1. Megraud F: Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am, 1993; 22: 73-88
2. Takashima T, Adachi K, Kawamura A, Yuki M, Fujishiro H, Rumi MA, Ishihara S, Watanabe M, Kinoshita Y: Cardiovascular risk factors in subjects with Helicobacter pylori infection. Helicobacter, 2002; 7: 86-90
3. Scharnagl H, Kist M, Grawitz AB, Koenig W, Wieland H, Marz W: Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol. Am J Cardiol, 2004; 93: 219-220
4. Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong Y, Kishi R: Relationship of Helicobacter pylori infection to arterial stiffness in Japanese subjects. Hypertens Res, 2005; 28: 283-292
5. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J, 1994; 71: 437-439
6. Markus HS, Mendall MA: Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry, 1998; 64: 104-107
7. Kowalski M: Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol, 2001; 52: 3-31
8. Kanbay M, Gur G, Yucel M, Yilmaz U, Boyacioglu S: Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci, 2005; 50: 1228-1231
9. Franceschi F, Leo D, Fini L, Santoliquido A, Flore R, Tondi P, Roccarina D, Nista EC, Cazzato AI, Lupascu A, Pola P, Silveri NG, Gasbarrini G, Gasbarrini A: Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature. Dig Liver Dis, 2005; 37: 301-308
10. Chimienti G, Russo F, Lamanuzzi BL, Nardulli M, Messa C, Di Leo A, Correale M, Giannuzzi V, Pepe G: Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein(a). Clin Biochem, 2003; 36: 359-365
11. Sotiropoulos A, Gikas A, Skourtis S, Merkouris P, Pentzeridis P, Polydorou A, Pappas S: Seropositivity to Chlamydia pneumoniae or Helicobacter pylori and coronary artery disease. Int J Cardiol, 2006; 109: 420-421
12. Rothenbacher D, Hoffmeister A, Bode G, Miller M, Koe-nig W, Brenner H: Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case control study with focus on markers of systemic inflammation and lipids. Atherosclerosis, 2001; 156: 193-199
13. Rosenstock SJ, Jorgensen T, Andersen LP, Bonnevie O: Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. Scand J Public Health, 2000; 28: 32-40
14. Mostaza JM, Camino N, Gerique JG, Pena R, Baquero M, Lahoz C: C-reactive protein levels and prevalence of chronic infections in subjects with hypoalphalipoproteinemia. Metabolism, 2005; 54: 33-37
15. Gillum RF: Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc, 2004; 96: 1470-476
16. Sasaki J, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Shimamoto K, Kono S, Itakura H: Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin. Circ J, 2006; 70: 810-814
17. Nieto FJ, Sorlie P, Comstock GW, Wu K, Adam E, Melnick JL, Szklo M: Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link? Arterioscler Thromb Vasc Biol, 1997; 17: 1780-1785
18. Niemela S, Karttunen T, Korhonen T, Laara E, Karttunen R, Ikaheimo M, Kesaniemi YA: Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart, 1996; 75: 573-575
19. Murray LJ, O'Reilly DP, Ong GM, O'Neill C, Evans AE, Bamford KB: Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile. Heart, 1999; 81: 239-244
20. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P: Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis, 1999; 142: 207-210
21. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut, 1993; 34: 1672-1676
22. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
23. Kawai T, Kawakami K, Kudo T, Ogiahara S, Handa Y, Moriyasu F: A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication. Intern Med, 2002; 41: 780-783
24. Woodward M, Morrison C, McColl K: An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol, 2000; 53: 175-181
25. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, Miki K, Graham DY: Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology, 1992; 102: 760-766
26. Murray LJ, McCrum EE, Evans AE, Bamford KB: Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland. Int J Epidemiol, 1997; 26: 880-887
27. Gidding SS, Stone NJ, Bookstein LC, Laskarzewski PM, Stein EA: Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents. J Pediatr, 1998; 133: 242-246
28. Jacobs DR Jr, Hebert B, Schreiner PJ, Sidney S, Iribarren C, Hulley S: Reduced cholesterol is associated with recent minor illness: the CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol, 1997; 146: 558-564
29. Sviridov D, Mukhamedova N, Remaley AT, Chin-Dusting J, Nestel P: Antiatherogenic functionality of high density lipoprotein: how much versus how good. J Atheroscler Thromb, 2008; 15: 52-62
30. von Eckardstein A, Nofer JR, Assmann G: High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol, 2001; 21: 13-27
31. Shah PK, Kaul S, Nilsson J, Cercek B: Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Circulation, 2001; 104: 2376-2383
32. Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D: Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol, 2007; 121: 229-238
33. Hoffmeister A, Rothenbacher D, Bode G, Persson K, Marz W, Nauck MA, Brenner H, Hombach V, Koenig W: Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol, 2001; 21: 427-432